A commercial partner before trials have finished and before regulatory approval?
Not my cup of tea.
A tech collaboration agreement into new applications would excite the market though, imho.
Ann: Leadership Transition, page-87
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
-0.050(2.44%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.00 | $2.00 | $14.46K | 7.234K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1521 | $2.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.05 | 504 | 1 |
View Market Depth
| Last trade - 10.32am 30/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |